Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Venetoclax
.
Show all posts
Showing posts with label
Venetoclax
.
Show all posts
Friday, May 26, 2017
BCL-2 inhibitor shows promise in AML patients
›
In continuation of my update on Venetoclax Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemothera...
Thursday, October 1, 2015
AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion
›
Venetoclax, also known as ABT-199 or GDC0199, is an orally bioavailable, selective small molecule inhibitor of the anti-apoptotic pr...
›
Home
View web version
